• Users Online: 575
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Mycobacterium tuberculosis Strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs

Heinrichs Marc Tobias, May Robert Justin, Heider Fabian, Reimers Tobias, B. Sy Sherwin Kenneth, Peloquin Charles Arthur, Derendorf Hartmut

Year : 2018| Volume: 7| Issue : 2 | Page no: 156-161

   This article has been cited by
 
1 N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents—the Synthesis and Biological Evaluation of Enantiomers
Martin Juhás,Lucie Kucerová,Ondrej Horácek,Ondrej Jandourek,Vladimír Kubícek,Klára Konecná,Radim Kucera,Pavel Bárta,Jirí Janoušek,Pavla Paterová,Jirí Kuneš,Martin Doležal,Jan Zitko
Molecules. 2020; 25(7): 1518
[Pubmed]  [Google Scholar] [DOI]
2 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
Weronika Ambrozkiewicz,Marta Kucerová-Chlupácová,Ondrej Jandourek,Klára Konecná,Pavla Paterová,Pavel Bárta,Jarmila Vinšová,Martin Doležal,Jan Zitko
Molecules. 2020; 25(7): 1561
[Pubmed]  [Google Scholar] [DOI]
3 Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis
Nada Lelovic,Katsuhiko Mitachi,Junshu Yang,Maddie R. Lemieux,Yinduo Ji,Michio Kurosu
The Journal of Antibiotics. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Electrochemistry of ring-substituted 1-hydroxynaphthalene-2-carboxanilides: Relation to structure and biological activity
Július Gajdár,Konstantina Tsami,Hana Michnová,Tomáš Gonec,Marie Brázdová,Zuzana Soldánová,Miroslav Fojta,Josef Jampílek,Jirí Barek,Jan Fischer
Electrochimica Acta. 2019; : 135485
[Pubmed]  [Google Scholar] [DOI]
5 Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular Mycobacterium tuberculosis
Zeinab G. Khalil,Timothy A. Hill,Luis M. De Leon Rodriguez,Rink-Jan Lohman,Huy N. Hoang,Norbert Reiling,Doris Hillemann,Margaret A. Brimble,David P. Fairlie,Antje Blumenthal,Robert J. Capon
Antimicrobial Agents and Chemotherapy. 2019; 63(3)
[Pubmed]  [Google Scholar] [DOI]
6 Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis
Jiayun Liu,Wanliang Shi,Shuo Zhang,Xiaoke Hao,Dmitry A. Maslov,Kirill V. Shur,Olga B. Bekker,Valery N. Danilenko,Ying Zhang
Frontiers in Microbiology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
7 Inhaled Antibiotics for Mycobacterial Lung Disease
Robert J. Banaschewski,Robert J. Hofmann
Pharmaceutics. 2019; 11(7): 352
[Pubmed]  [Google Scholar] [DOI]
8 Synthesis, characterization, and in vitro evaluation of gamma radiation-induced PEGylated isoniazid
Maykel González Torres,Silvia Guzman Beltrán,Marco A. Mata Gómez,José González Valdez,Gerardo Leyva Gómez,Yaaziel Melgarejo Ramírez,Witold Brostow,Cristina Velasquillo Martínez,Joaquín Zúńiga Ramos,Rogelio Rodríguez Talavera
Electronic Journal of Biotechnology. 2019;
[Pubmed]  [Google Scholar] [DOI]
9 Bioactivity of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides: Comparative Molecular Surface Analysis
Hana Michnová,Šárka Pospíšilová,Tomáš Gonec,Iva Kapustíková,Peter Kollár,Violetta Kozik,Robert Musiol,Izabela Jendrzejewska,Ján Vanco,Zdenek Trávnícek,Alois Cížek,Andrzej Bak,Josef Jampílek
Molecules. 2019; 24(16): 2991
[Pubmed]  [Google Scholar] [DOI]
10 Antimycobacterial Activity of Cinnamaldehyde in a Mycobacterium tuberculosis(H37Ra) Model
Rafal Sawicki,Joanna Golus,Agata Przekora,Agnieszka Ludwiczuk,Elwira Sieniawska,Grazyna Ginalska
Molecules. 2018; 23(9): 2381
[Pubmed]  [Google Scholar] [DOI]
11 Dose optimization of moxifloxacin and linezolid against tuberculosis using mathematical modeling and simulation
M. Tobias Heinrichs,George L. Drusano,David L. Brown,Michael S. Maynard,Sherwin K.B. Sy,Kenneth H. Rand,Charles A. Peloquin,Arnold Louie,Hartmut Derendorf
International Journal of Antimicrobial Agents. 2018;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article